**Core Concept**
Osteoporosis is a metabolic bone disorder characterized by a decrease in bone mass and density, leading to an increased risk of fractures. This condition is primarily caused by an imbalance between bone resorption and bone formation.

**Why the Correct Answer is Right**
In osteoporosis, the activity of osteoclasts, which are responsible for bone resorption, exceeds the activity of osteoblasts, which are responsible for bone formation. This imbalance leads to a net loss of bone mass and density. The RANK/RANKL/OPG system plays a crucial role in regulating osteoclast activity. RANKL (receptor activator of NF-κB ligand) binds to RANK on osteoclasts, promoting their activation and survival, while OPG (osteoprotegerin) acts as a decoy receptor for RANKL, inhibiting its activity.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specifically address the underlying pathophysiology of osteoporosis. While an imbalance between bone resorption and formation is indeed a key feature of osteoporosis, this option is too vague.

**Option B:** This option is incorrect because it refers to a different condition altogether. Osteomalacia is a disorder of mineralization in bone, characterized by softening of the bones, and is not directly related to the pathophysiology of osteoporosis.

**Option C:** This option is incorrect because while it mentions an imbalance between bone resorption and formation, it does not specify the RANK/RANKL/OPG system, which is a critical regulator of osteoclast activity in osteoporosis.

**Clinical Pearl / High-Yield Fact**
The RANK/RANKL/OPG system is a key target for therapeutic interventions in osteoporosis. Bisphosphonates, which are commonly used to treat osteoporosis, work by inhibiting osteoclast activity and thereby reducing bone resorption.

**Correct Answer:** C.